Computational Aids for Assessing Bioactivities

Computational Phytochemistry

Volumn , Issue , 2018, Pages 277-300

  Wolfram, Evelyn ^a   Trifan, Adriana ^b  

^a ZURICH UNIVERSITY OF APPLIED SCIENCES   (Switzerland)

^b GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Bioinformatics; Bioprospecting; Data mining; Databases and data analysis; In silico screening; In vitro bioassays; Modelling; Statistical tools

Indexed keywords

EID: 85077882033     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-812364-5.00010-9     Document Type: Chapter

References (95)

1. Amigoni F., Schiaffonati V. The multiagent technology and paradigm within scientific discovery Int. J. Artif. Intell. Tools 16 2 2007 219-242 10.1142/S0218213007003291.
2. Atanasov A.G., Waltenberger B., Pferschy-Wenzig E.M., Linder T., Wawrosch C., Uhrin P., Temml V., Wang L., Schwaiger S., Heiss E.H., Rollinger J.M., Schuster D., Breuss J.M., Bochkov V., Mihovilovic M.D., Kopp B., Bauer R., Dirsch V.M., Stuppner H. Discovery and resupply of pharmacologically active plant-derived natural products: a review Biotechnol. Adv. 33 2015 1582-1614 10.1016/j.biotechadv.2015.08.001.
3. Bansal A., Chhabra V., Ravindra K., Rawal R.K., Sharma S. Chemometrics: a new scenario in herbal drug standardization J. Pharm. Anal. 4 2014 223-233 10.1016/j.jpha.2013.12.001.
4. Barrett J.E., McGonigle P. Rodent models for Alzheimer’s disease in drug discovery In: Adejare A. Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders 2017 Elsevier Amsterdam 235-247.
5. Beato B., Pisek A., White J., Grever T., Engel B., Pugh M., Schneider M., Carel B., Branstrator L., Shoup R. Going paperless: implementing an electronic laboratory notebook in a bioanalytical laboratory Bioanalysis 3 2011 1457-1470 10.4155/BIO.11.117.
6. Boccard J., Rudaz S. Harnessing the complexity of metabolomics data with chemometrics J. Chemometr. 28 2014 1-9 10.1002/cem.2567.
7. Bräm S., Wolfram E. Recent advances in effect-directed enzyme assays based on thin-layer chromatography Phytochem. Anal. 28 2017 74-78 10.1002/pca.2669.
8. Brogi S., Taf A., Désaubry L., Nebigil C.G. Discovery of GPCR ligands for probing signal transduction pathways Front. Pharmacol. 5 2014 255 10.3389/fphar.2014.00255.
9. Bucar F., Wolfram E. Bioassay-coupled chromatography: challenges and applications in natural product research Phytochem. Anal. 28 2017 73 10.1002/pca.2675.
10. Butterweck V., Nahrstedt A. What is the best strategy for preclinical testing of botanicals? A critical perspective Planta Med. 78 2012 747-754 10.1055/s-0031-1298434.
11. Cabral G.A., Griffin-Thomas L. Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation Expert Rev. Mol. Med. 11 2009 e3 10.1017/S1462399409000957.
12. Carnovali M., Ottria R., Pasqualetti S., Banfi G., Ciuffreda P., Mariotti M. Effects of bioactive fatty acid amide derivatives in zebrafish scale model of bone metabolism and disease Pharmacol. Res. 104 2016 1-8 10.1016/j.phrs.2015.12.009.
13. Chen Y.C. Beware of docking! Trends Pharmacol. Sci. 36 2015 78-95 10.1016/j.tips.2014.12.001.
14. Choi W., Kim B., Cho H., Lee D., Lee H. A corpus for plant-chemical relationships in the biomedical domain BMC Bioinf. 17 2016 386-400 10.1186/s12859-016-1249-5.
15. Choma I.M., Grzelak E.M. Bioautography detection in thin-layer chromatography J. Chromatogr. A 1218 2011 2684-2691.
16. Curtis C.G., Bilyard K., Stephenson H. ex vivo metrics, a preclinical tool in new drug development J. Transl. Med. 6 2008 5 10.1186/1479-5876-6-5.
17. Das S., Laskar M.A., Sarker S.D., Choudhury M.D., Choudhury P.R., Mitra A., Jamil S., Lathiff S.M.A., Abdullah S.A., Basar N., Nahar L., Talukdara A.D. Prediction of anti-Alzheimer’s activity of flavonoids targeting acetylcholinesterase in silico Phytochem. Anal. 28 2017 324-331 10.1002/pca.2679.
18. Deveau A.P., Bentley V.L., Berman J.N. Using zebrafish models of leukemia to streamline drug screening and discovery Exp. Hematol. 45 2017 1-9 10.1016/j.exphem.2016.09.012.
19. Dhopeshwarkar A., Mackie K. CB2 Cannabinoid receptors as a therapeutic target-what does the future hold? Mol. Pharmacol. 86 2014 430-437 10.1124/mol.114.094649.
20. Donno D., Beccaro G.L., Carlen C., Ançay A., Cerutti A.K., Mellano M.G., Bounous G. Analytical fingerprint and chemometrics as phytochemical composition control tools in food supplement analysis: characterization of raspberry bud preparations of different cultivars J. Sci. Food Agric. 96 2016 3157-3168 10.1002/jsfa.7494.
21. Eliasson M., Rännar S., Trygg J. From data processing to multivariate validation -essential steps in extracting interpretable information from metabolomics data Curr. Pharm. Biotechnol. 12 2011 996-1004 10.2174/138920111795909041.
22. Favre-Godal Q., Queiroz E.F., Wolfender J.L. Latest developments in assessing antifungal activity using TLC-bioautography: a review J. AOAC Int. 96 2013 1175-1188 10.5740/jaoacint.SGEFavre-Godal.
23. Fichou D., Ristivojević P., Morlock G.E. Proof-of-principle of rTLC, an open-source software developed for Image evaluation and multivariate analysis of planar chromatograms Anal. Chem. 88 2016 12494-12501 10.1021/acs.analchem.6b04017.
24. Gasteiger J., Teckentrup A., Terfloth L., Spycher S. Neural networks as data mining tools in drug design J. Phys. Org. Chem. 16 2003 232-245 10.1002/poc.597.
25. Gertsch J., Raduner S., Altmann K.H. New natural noncannabinoid ligands for cannabinoid type-2 (CB2) receptors J. Recept. Signal Transduct. Res. 26 2006 709-730 10.1080/10799890600942674.
26. Gertsch J., Leonti M., Raduner S., Racz I., Chen J.Z., Xie X.Q., Altmann K.H., Karsak M., Zimmer A. Beta-caryophyllene is a dietary cannabinoid Proc. Natl. Acad. Sci. U. S. A. 105 2008 9099-9104.
27. Goel R.K., Singh D., Lagunin A., Poroikov V. PASS-assisted exploration of new therapeutic potential of natural products Med. Chem. Res. 20 2011 1509-1514 10.1007/s00044-010-9398-y.
28. Gómez-Gálvez Y., Palomo-Garo C., Fernández-Ruiz J., García C. Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson’s disease Prog. Neuropsychopharmacol. Biol. Psychiatry 64 2016 200-208 10.1016/j.pnpbp.2015.03.017.
29. Heinrich M., Jäger A.K. Ethnopharmacology, ULLA Series in Pharmaceutical Sciences 2016 Wiley-Blackwell Chichester.
30. Héberger K. Quantitative structure-(chromatographic) retention relationships J. Chromatogr. A 1158 2007 273-305 10.1016/j.chroma.2007.03.108.
31. Höck S., Riedl R. CyBy2: a structure-based data management tool for chemical and biological data Chimia 66 2012 132-134 10.2533/chimia.2012.132.
32. Hoon S., St Onge R.P., Giaever G., Nislow C. Yeast chemical genomics and drug discovery: an update Trends Pharmacol. Sci. 29 2008 499-504 10.1016/j.tips.2008.07.006.
33. Hunter A., Dayalan S., De Souza D., Power B., Lorrimar R., Szabo T., Nguyen T., O’Callaghan S., Hack J., Pyke J., Nahid A., Barrero R., Roessner U., Likic V., Tull D., Bacic A., McConville M., Bellgard M. MASTR-MS: a web-based collaborative laboratory information management system (LIMS) for metabolomics Metabolomics 13 2017 14 10.1007/s11306-016-1142-2.
34. Imming P., Sinning C., Meyer A. Drugs, their targets and the nature and number of drug targets Nat. Rev. Drug Discov. 5 2006 821-834 10.1038/nrd2132.
35. Jansen J.J., Smit S., Hoefsloot H.C.J., Smilde A.K. The photographer and the greenhouse: how to analyse plant metabolomics data Phytochem. Anal. 21 2010 48-60 10.1002/pca.1181.
36. Jensen K., Panagiotou G., Kouskoumvekaki I. NutriChem: a systems chemical biology resource to explore the medicinal value of plant-based foods Nucleic Acids Res. 43 2015 D940-D945 10.1093/nar/gku724.
37. Kaliszan R. Quantitative structure-chromatographic retention relationships Chem. Rev. 107 2007 3212-3246 10.1021/cr068412z.
38. Kizawa H., Nagao E., Shimamura M., Zhang G., Torii H. Scaffold-free 3D bio-printed human liver tissue stably maintains metabolic functions useful for drug discovery Biochem. Biophys. Rep. 10 2017 186-191 10.1016/j.bbrep.2017.04.004.
39. Kubinyi H. Drug research: myths, hype and reality Nat. Rev. Drug Discov. 2 2003 665-668 10.1038/nrd1156.
40. Laprairie R.B., Bagher A.M., Denovan-Wright E.M. Cannabinoid receptor ligand bias: implications in the central nervous system Curr. Opin. Pharmacol. 32 2017 32-43 10.1016/j.coph.2016.10.005.
41. Larsson J., Gottfries J., Muresan S., Backlund A. ChemGPS-NP: tuned for navigation in biologically relevant chemical space J. Nat. Prod. 70 2007 789-794 10.1021/np070002y.
42. Lee J., Bogyo M. Target deconvolution techniques in modern phenotypic profiling Curr. Opin. Chem. Biol. 17 2013 118-126 10.1016/j.cbpa.2012.12.022.
43. Leonti M. The future is written: impact of scripts on the cognition, selection, knowledge and transmission of medicinal plant use and its implications for ethnobotany and ethnopharmacology J. Ethnopharmacol. 134 2011 542-555 10.1016/j.jep.2011.01.017.
44. Leonti M., Stafford G.I., Cero M.D., Cabras S., Castellanos M.E., Casu L., Weckerle C.S. Reverse ethnopharmacology and drug discovery J. Ethnopharmacol. 198 2017 417-431 10.1016/j.jep.2016.12.044.
45. Li J.W.H., Vederas J.C. Drug discovery and natural products: end of an era or an endless frontier? Science 325 2009 161-165 10.1126/science.1168243.
46. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 46 2001 3-26 10.1016/j.addr.2012.09.019.
47. Luni C., Serena E., Elvassore N. Human-on-chip for therapy development and fundamental science Curr. Opin. Biotechnol. 25 2014 45-50 10.1016/j.copbio.2013.08.015.
48. Luo Z., Liu Y., Zhao B., Tang M., Dong H., Zhang L., Lv B., Wei L. ex vivo and in situ approaches used to study intestinal absorption J. Pharmacol. Toxicol. Methods 68 2013 208-216 10.1016/j.vascn.2013.06.001.
49. Markt P., Feldmann C., Rollinger J.M., Raduner S., Schuster D., Kirchmair J., Distinto S., Spitzer G.M., Wolber G., Laggner C., Altmann K.H., Langer T., Gertsch J. Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflow J. Med. Chem. 52 2009 369-378 10.1021/jm801044g.
50. Marston A. Thin-layer chromatography with biological detection in phytochemistry J. Chromatogr. A 1218 2011 2676-2683 10.1016/j.chroma.2010.12.068.
51. Martin J.G., Novali M. Small animals models for drug discovery Pulm. Pharmacol. Ther. 24 2011 513-524 10.1016/j.pupt.2011.05.002.
52. Misra B.B., Fahrmann J.F., Grapov D. Review of emerging metabolomics tools and resources: 2015-2016 Electrophoresis 2017 (in press) https://doi.org/10.1002/elps.201700110.
53. Molnar I. Computerized design of separation strategies by reversed-phase liquid chromatography: development of DryLab software J. Chromatogr. A 965 2002 175-194 10.1016/S0021-9673(02)00731-8.
54. Muigg P., Rosén J., Bohlin L., Backlund A. In silico comparison of marine, terrestrial and synthetic compounds using ChemGPS-NP for navigating chemical space Phytochem. Rev. 12 2013 449-457 10.1007/s11101-012-9256-2.
55. Munro G., Jansen-Olesen I., Olesen J. Animal models of pain and migraine in drug discovery Drug Discov. Today 22 2017 1103-1111 10.1016/j.drudis.2017.04.016.
56. Nikitas P., Pappa-Louisi A. Retention models for isocratic and gradient elution in reversed-phase liquid chromatography J. Chromatogr. A 1216 2009 1737-1755 10.1016/j.chroma.2008.09.051.
57. O’Reilly L.P., Luke C.J., Perlmutter D.H., Silverman G.A., Pak S.C. C. elegans in high-throughput drug discovery Adv. Drug Deliv. Rev. 69-70 2014 247-253 10.1016/j.addr.2013.12.001.
58. Pacher P., Bátkai S., Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy Pharmacol. Rev. 58 2006 389-462 10.1124/pr.58.3.2.
59. Pak M.E., Kim Y.R., Kim H.K., Ahn S.M., Shin H.K., Baek J.U., Choi B.T. Studies on medicinal herbs for cognitive enhancement based on the text mining of Dongeuibogamand preliminary evaluation of its effects J. Ethnopharmacol. 179 2016 383-390 10.1016/j.jep.2016.01.006.
60. Parasuraman S. Toxicological screening J. Pharmacol. Pharmacother. 2 2011 74-79 10.4103/0976-500X.81895.
61. Peng W., Unutmaz D., Ozbolat I.T. Bioprinting towards physiologically relevant tissue models for pharmaceutics Trends Biotechnol. 34 2016 722-732 10.1016/j.tibtech.2016.05.013.
62. Pertwee R.G. The pharmacology of cannabinoid receptors and their ligands: an overview Int. J. Obes. (Lond) 30 Suppl 1 2006 S13-18 10.1038/sj.ijo.0803272.
63. Pirhadi S., Sunseri J., Koes D.R. Open source molecular modeling J. Mol. Graph. Model. 69 2016 127-143 10.1016/j.jmgm.2016.07.008.
64. Poso A., Huffman J.W. Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands Br. J. Pharmacol. 153 2008 335-346 10.1038/sj.bjp.0707617.
65. Potterat O., Hamburger M. Concepts and technologies for tracking bioactive compounds in natural product extracts: generation of libraries, and hyphenation of analytical processes with bioassays Nat. Prod. Rep. 30 2013 546-564 10.1039/C3NP20094A.
66. Raduner S., Majewska A., Chen J.Z., Xie X.Q., Hamon J., Faller B., Altmann K.H., Gertsch J. Alkylamides from Echinacea are a new class of cannabinomimetics J. Biol. Chem. 281 2006 14192-14206 10.1074/jbc.M601074200.
67. Rask-Andersen M., Almen M.S., Schioth H.B. Trends in the exploitation of novel drug targets Nat. Rev. Drug Discov. 10 2011 579-590 10.1038/nrd3478.
68. Rausch O. High content cellular screening Curr. Opin. Chem. Biol. 10 2006 316-320 10.1016/j.cbpa.2006.06.004.
69. Rollinger J.M., Langer T., Stuppner H. Integrated in silico tools for exploiting the natural products’ bioactivity Planta Med. 72 2006 671-678 10.1055/s-2006-941506.
70. Rollinger J.M., Stuppner H., Langer T. Virtual screening for the discovery of bioactive natural products In: Petersen F., Amstutz R. Natural Compounds as Drugs Volume IProgress in Drug Research Book Series vol. 65 2008 Birkhäuser Verlag AG Basel/Boston, MA/Berlin 211-249.
71. Rollinger J.M., Schuster D., Danzl B., Schwaiger S., Markt P., Schmidtke M., Gertsch J., Raduner S., Wolber G., Langer T., Stuppner H. In silico target fishing for rationalized ligand discovery exemplified on constituents of Ruta graveolens Planta Med. 75 2009 195-204 10.1055/s-0028-1088397.
72. Rosén J., Lövgren A., Kogej T., Muresan S., Gottfries J., Backlund A. ChemGPS-NPWeb: chemical space navigation online J. Comput. Aided Mol. Des. 23 2009 253-259 10.1007/s10822-008-9255-y.
73. Roussel S., Preys S., Chauchard F., Lallemand J. Multivariate data analysis (chemometrics) In: O’Donnell C., Fagan C., Cullen P. Process Analytical Technology for the Food Industry Food Engineering Series 2014 Springer New York, NY 7-14.
74. Ruiu S., Anzani N., Orrù A., Floris C., Caboni P., Maccioni E., Distinto S., Alcaro S., Cottiglia F. N-Alkyl dien-and trienamides from the roots of Otanthus maritimus with binding affinity for opioid and cannabinoid receptors Bioorg. Med. Chem. 21 2013 7074-7082 10.1016/j.bmc.2013.09.017.
75. Sadym A., Lagunin A., Filimonov D., Poroikov V. Prediction of biological activity spectra via the internet SAR QSAR Environ. Res. 14 2003 10.1080/10629360310001623935.
76. Schenone M., Dancik V., Wagner B.K., Clemons P.A. Target identification and mechanism of action in chemical biology and drug discovery Nat. Chem. Biol. 9 2013 232-240 10.1038/nchembio.1199.
77. Schuster D. 3D pharmacophores as tools for activity profiling Drug Discov. Today Technol. 7 2010 e205-211 10.1016/j.ddtec.2010.11.006.
78. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks Genome Res. 13 2013 2498-2504 10.1101/gr.1239303.
79. Sharma C., Sadek B., Goyal S.N., Sinha S., Kamal M.A., Ojha S. Small molecules from nature targeting G-protein coupled cannabinoid receptors: potential leads for drug discovery and development Evid. Based Complement. Alternat. Med. 238482 2015 10.1155/2015/238482.
80. Soethoudt M., Grether U., Fingerle J., Grim T.W., Fezza F., de Petrocellis L., Ullmer C., Rothenhausler B., Perret C., van Gils N., Finlay D., MacDonald C., Chicca A., Gens M.D., Stuart J., de Vries H., Mastrangelo N., Xia L., Alachouzos G., Baggelaar M.P., Martella A., Mock E.D., Deng H., Heitman L.H., Connor M., Di Marzo V., Gertsch J., Lichtman A.H., Maccarrone M., Pacher P., Glass M., van der Stelt M. Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity Nat. Commun. 8 2017 13958 10.1038/ncomms13958.
81. Stepnik K., Malinowska I. Skin-mimetic chromatography for prediction of human percutaneous absorption of biologically active compounds occurring in medicinal plant extracts Biomed. Chromatogr. 31 2017 1-10 10.1002/bmc.3922.
82. Steuer R. On the analysis and interpretation of correlations in metabolomic data Brief. Bioinform. 7 2006 151-158 10.1093/bib/bbl009.
83. Strohl W.R. The role of natural products in a modern drug discovery program Drug Discov. Today 5 2000 39-41.
84. Svízenská I., Dubový P., Sulcová A. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures-a short review Pharmacol. Biochem. Behav. 90 2008 501-511 10.1016/j.pbb.2008.05.010.
85. Trygg J., Gullberg J., Johansson A.I., Jonsson P., Moritz T. Chemometrics in metabolomics-an introduction In: Saito K., Dixon R.A., Willmitzer L. Plant MetabolomicsBiotechnology in Agriculture and Forestry vol. 57 2006 Springer Berlin/Heidelberg 117-128.
86. Turi C.E., Finley J., Shipley P.R., Murch S.J., Brown P.N. Metabolomics for phytochemical discovery: development of statistical approaches using a cranberry model system J. Nat. Prod. 78 2015 953-966 10.1021/np500667z.
87. van der Kooy F., Maltese F., Choi Y.H., Kim H.K., Verpoorte R. Quality control of herbal material and phytopharmaceuticals with MS and NMR based metabolic fingerprinting Planta Med. 75 2009 763-775 10.1055/s-0029-1185450.
88. Vogel H.G., Vogel W. Drug Discovery and Evaluation 2002 Springer New York.
89. Wang B., Deng J., Gao Y., Zhu L., He R., Xu Y. The screening toolbox of bioactive substances from natural products: a review Fitoterapia 82 2011 1141-1151 10.1016/j.fitote.2011.08.007.
90. Wang Y., Jin Y., Zhou C., Qu H., Cheng Y. Discovering active compounds from mixture of natural products by data mining approach Med. Biol. Eng. Comput. 46 2008 605-611 10.1007/s11517-008-0323-1.
91. Whiteside G.T., Pomonis J.D., Kennedy J.D. An industry perspective on the role and utility of animal models of pain in drug discovery Neurosci. Lett. 557 2013 65-72 10.1016/j.neulet.2013.08.033.
92. Wise A., Gearing K., Rees S. Target validation of G-protein coupled receptors Drug Discov. Today 7 2002 235-246 10.1016/S1359-6446(01)02131-6.
93. Wolber G., Langer T. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters J. Chem. Inf. Model. 45 2005 160-169 10.1021/ci049885e.
94. Wood A.J., Lo T.W., Zeitler B., Pickle C.S., Ralston E.J., Lee A.H., Amora R., Miller J.C., Leung E., Meng X., Zhang L., Rebar E.J., Gregory P.D., Urnov F.D., Meyer B.J. Targeted genome editing across species using ZFNs and TALENs Science 333 2011 307 10.1126/science.1207773.
95. Yi H.G., Lee H., Cho D.W. 3D printing of organs-on-chips Bioengineering 4 2017 10 10.3390/bioengineering4010010.